Colinz Laboratories

59.00
-2.38
(-3.88%)
Market Cap (₹ Cr.)
₹28
52 Week High
84.40
Book Value
₹
52 Week Low
35.20
PE Ratio
55.80
PB Ratio
2.55
PE for Sector
56.33
PB for Sector
19.83
ROE
5.62 %
ROCE
26.20 %
Dividend Yield
0.00 %
EPS
₹1.10
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-0.31 %
Net Income Growth
6.41 %
Cash Flow Change
157.50 %
ROE
-3.22 %
ROCE
-3.76 %
EBITDA Margin (Avg.)
5.03 %

Financial Results

Balance Sheet

Cash Flow

Share Holding

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
3,457.80 1,13,396.13 67.77 10,785.75 11.59 1,656 20.90 59.79
3,131.50 40,029.33 46.89 4,293.31 11.77 816 18.09 50.05
1,800.45 29,827.48 41.31 5,834.96 50.97 772 -25.94 31.54
1,366.70 19,189.53 50.45 2,032.96 19.85 397 -4.52 53.95
1,939.60 14,591.21 30.55 1,761.04 15.65 461 19.85 55.22
318.35 12,428.02 37.21 2,227.83 16.55 315 26.45 74.87
866.65 8,286.31 201.75 1,159.77 8.64 32 1,091.53 62.23
1,388.70 3,442.01 103.09 207.35 40.06 34 - 53.21
801.50 2,260.09 53.07 192.42 12.50 21 -34.09 54.23
22.71 2,090.56 74.13 238.85 3.11 20 73.41 54.61

Corporate Action

Technical Indicators

RSI(14)
Neutral
46.36
ATR(14)
Volatile
2.67
STOCH(9,6)
Neutral
23.28
STOCH RSI(14)
Oversold
16.76
MACD(12,26)
Bearish
-0.06
ADX(14)
Weak Trend
18.71
UO(9)
Bearish
31.70
ROC(12)
Uptrend But Slowing Down
1.58
WillR(14)
Oversold
-87.52